Croarkin Richard 4
4 · Clearside Biomedical, Inc. · Filed Jun 21, 2024
Insider Transaction Report
Form 4
Croarkin Richard
Director
Transactions
- Award
Stock Option (right to buy)
2024-06-20+45,000→ 45,000 totalExercise: $1.15Exp: 2034-06-19→ Common Stock (45,000 underlying)
Footnotes (1)
- [F1]The shares underlying this option vest in full on the earlier of the Issuer's next annual meeting of stockholders or June 20, 2025, subject to the Reporting Person's continuous service as of such vesting date.